Jaap van Doesum

16PUBLICATIONS
215CO-AUTHORS
HaematologyPredictive and prognostic markersCardiology (incl. cardiovascular diseases)Haematological tumoursCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 16, 2025
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections, and survival after CART in R/R LBCL.

Janneke W de Boer, Kylie Keijzer, Suzanne van Dorp

|Jul 23, 2024
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.

Anne Mea Spanjaart, Per Ljungman, Gloria Tridello

|May 21, 2024
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.

Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi

|Feb 22, 2024
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.

Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi

|Nov 15, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.

Shaimaa El-Ashwah, Jon Salmanton-García, Yavuz M Bilgin

|Aug 28, 2023
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.

Janneke W de Boer, Elise R A Pennings, Ankie Kleinjan

Pageof 3

Frequent Collaborators

9 joint publications

Livio Pagano

9 joint publications

Francesco Marchesi

9 joint publications

Jon Salmanton-García

9 joint publications

Oliver A Cornely